www.sss403.com_老品牌信最新申博网址

社友网

2019-10-22 12:05:41

字体:标准

  Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.

  Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.

  In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.

  TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.

  AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.

  TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.

  TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.

  In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.

  TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.

  ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.

  HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.

  In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.

  Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.

  Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.

  ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.

  In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.

  “EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.

  Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.

  In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.

  Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.

  In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.

  In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.

  Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”

  Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.

  TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.ELIAV:HCV[hepatitisCvirus]infectionisablood-bornedisease.Peoplebecomeinfectedwhenexposedtocontaminatedbloodproductsorcontaminatedsyringesorinjectionequipment.TheincidenceofHCVinfection(thenknownasnon-A/non-Bhepatitis)priorto1965waslow;however,therateincreasedsteadilyintothe1980s.In1988,HCVwasidentifiedandbloodsupplyscreeningforHCVbecameavailablein1992.Peoplegotinfectedandusuallydidn'tknowitbecausetheacuteinfectionistypicallyasymptomatic.Afterprolongedinfection,20to25years,orso,peoplewerepresentingwithadvancedliverdamage,whichcanleadtocirrhosisandeventuallyevenliverfailureorlivercancer.Ahugecohortofbabyboomersgotinfected,didn'tknowit,aregraduallygettingdiagnosedandfindingtheirdiseaseissoadvancedthattheyareapproachingacrisispoint.Theclockistickingonthisproblem.In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.

  HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.“EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.

  “EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.

  Overthelast20years,MSD’svaccineoperationsinEuropehavebeenpartofajointventurebetweenthecompaniesSanofiandMSD,calledSanofiPasteurMSD(SPMSD).SanofiPasteurMSD—ownedona50/50basisbySanofiPasteurandMSD—wascreatedin1994todevelopandcommercializevaccinesoriginatingfrombothcompanies’pipelinestoimproveandpromotepublichealthin19Europeancountries.Aftercarefullyconsideringourindividualstrategicpriorities,alongsidetheeconomicandregulatoryenvironmentsforvaccineoperationsintheEuropeanUnion,bothcompaniesmutuallyagreedinMarchof2016thatitisinourbestintereststomanageourvaccineproductportfoliosindependently.SanofiPasteurandMSDbelievethatreintegratingtheirrespectivevaccineportfoliosintotheircompanies’operationswillbetterpositionthemtodrivegrowth,executemoreefficiently,optimizevaccinecoverageandbringnewvaccinestomarketmorequickly.Eachcompanywillnowbeabletodefineitsownvaccinesstrategytobenefitpublichealthandcreatevalueforpatients,healthcareprofessionalsandpayers.Throughouttheyear,SPMSDanditsshareholdershavebeenfocusedonasmoothandorderlytransitionwhileachievingtheirpublichealthcaregoalsandupholdingtheircommitmentstotheiremployees,customersandbusinesspartners.Followingthistransitionalperiod,bothcompanieshaveconfirmedthatDec.31,2016willbetheofficialclosingdateoftheendoftheirvaccinesjointventureSanofiPasteurMSD(SPMSD),followingclearancesrecentlygrantedbytheEuropeanCommission.AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.TheMSDFellowshipforGlobalHealthisonewayMSDishelpinganswertheglobalhealthneedsoftheunderserved.MSDemployeeswhoparticipateintheprogramarecalledRichardT.ClarkFellows(RTCFellows)inhonorofretiredChairmanandCEORichardT.Clarkandhisphilosophyofpassion,purposeandcommitmenttocorporateresponsibility.Launchedin2012,theprogramoffersMSDemployeesopportunitiestosharetheirskillswithpeoplearoundtheworld.Asmanyas30Fellowsareselectedeachyear;theexpertiseoftheapplicantsismatchedtotheneedsofthepartnerorganizations.Duringthethree-monthassignments,theFellowsareembeddedwithinanon-profitorganizationinthefield.

  “EventhoughDr.Alzheimercharacterizedthediseasein1906,itwasn’tuntilthelastfewdecadesthatthediseasebecamerecognizedasarealillnessseparatefromnormalagingandotherformsofdementia,”saidDarryleSchoepp,Ph.D.,vicepresidentandtherapeuticareahead,Neuroscience,MSD.“Nowpeoplearelivinglonger,andwecanseehowthediseaseworks,”saidDavidMichelson,M.D.,vicepresident,ClinicalNeuroscienceResearch,MSD.“Scienceisataplacewherenotonlydoweunderstandmoreaboutit,butweareexploringwaystodosomethingaboutit.”“Newtechnologiesareallowingtheidentificationofearlydiseasesignswhichwehopewillallowustointervenepromptlyinordertosloworhaltprogression.That’stheholygrail.Whatyouwanttodoistohavesomethingthatworksandtobeabletouseitbeforethediseaserobspeopleofwhotheyreallyare,”saidDr.Michelson.Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.

  In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.

  AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.Overthepast125years,we’veseentheworldchangethroughthepowerofmedicineandinvention.Whileeachpivotalmilestonehasbeenunique,onethingtheyhaveincommonisthatwehaven’tdoneitalone.AtMSD,wehavealwaysbelievedthatgreatmedicalbreakthroughsrelyonteamwork–fromwithinandoutsideofMSD–andourhistoryhasprovenit.Weareproudtohaveworkedinpartnershipwithcompanies,academics,governments,patientorganizations,healthcareprofessionals,nongovernmentalorganizations(NGOs),multilateralorganizationsandothersintheprivatesector--tohelpimprovelivesaroundtheworldandcontinuetosolvesomeoftheworld’smostseriousillnesses.

  Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.Intheearly1990s,HedyTepplerwastreatingAIDSpatientswithHIV/AIDSatahospitalinPhiladelphia.ShewasalsoservingasaclinicaltrialinvestigatorforPhase1and2MSDstudiesofanewclassofanti-HIVdrugsdesignedtoblocktheHIVproteaseenzymeandthuspreventHIVreplication."Theearlyresultswereexciting.Inashorttime,manypatientsrespondedtotheinvestigationaltreatment,"saysHedy.HerpositiveexperienceduringtheseandsubsequentclinicaltrialswaslargelywhyshejoinedMSDin1996."Iwantedtobemoreinvolvedindrugdevelopmentandclinicaltrialdesign,andMSDwasdoingsomegroundbreakingworkinHIV,"saysHedy,whonowservesasexecutivedirector,ClinicalResearch,InfectiousDiseases,atMSDResearchLaboratories.TheyearbeforeHedyarrived,anotherprominentHIVresearcherandthoughtleaderwaskeepingaclosewatchonMSD'swork.Bach-YenNguyen,nowretired-executivedirector,sectionhead,HCVandHIV,decidedtoleavetheNationalInstitutesofHealthtoworkonMSD'sHIVresearchdevelopmentteam.Bach-YenhadspentyearstreatingAIDSpatientsandworkinginHIVresearchandsawgreatpotentialinMSD'swork."WewerefacedwithanopportunitytohelppatientsinfectedwithHIV."ForBach-Yen,whoalsomadevitalcontributionstothedevelopmentofanotheroneofMSD'smedicinesforthetreatmentofHIV,thedrug'sapprovalcontinuestobehermostmemorablemomentatMSD."Weworkedlonghours.ThereweretimeswhenIcouldn'tattendschooleventswithmyson.WhenpeopleaskedhimwhereIwas,hewouldsay,'MomisbusyhelpingpeoplewithAIDS.'Hewasonly12,butheunderstoodtheimportanceofthework."Withinafewyears,theteamachievedadditionalsuccess:In2011,theFDAapprovedachewabletabletformofthisfirstagentinanewclassofanti-HIVagentsforchildren2yearsandolder,andin2013,approvedgranulesfororalsuspensionforinfants4weeksandolder."Ourpediatricsprogramhasbeenextremelysatisfyingasthereisatremendousneedfornewanti-HIVagentsthatcanbeusedacrosstheentirepediatricagerange,"saysHedy,wholeadstheIsentresspediatricdevelopmentprogram.Ourdiscoveryscientists“strivetomaketheimpossiblepossible,”saysJoeMiletich.Andheshouldknow:AstheseniorvicepresidentofDiscoveryPreclinicalandEarlyDevelopment,heleadsateamofresearcherswhoarechargedwithmakingthings“possiblethatweren’tpossiblebefore.”Hecontinues:“Webelievedrugdiscoveryisfoundationalforustocontinuebringingcriticalmedicinestotheworld.”About14,500peopleareinvolvedinscientificresearchatMSD.OurRDcolleaguesarealltaskedwiththesamemission:tosolvethepuzzlesofhumandiseasebiologyandthentranslatethosefindingsintonewtherapiesforpatients.Theyaredriventopushtheboundariesofscienceandtothentransformtheirdiscoveriesintomeaningfulnewtherapeutics.

  TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.In2016,MSDcelebratedits125thanniversaryasaglobalhealthcareleader.Wecreatedthispageasacelebrationofouraccomplishmentsaswellastohighlightwhatwe'reexcitedaboutfortheyearstocome.Thisisanexcitingtimeforourcompanyandtheworld.Today,weareattheforefrontofinventingtoolsforthefightagainstsomeoftheworld’smosturgentglobalhealthchallenges.Thisincludesmorethan30differentcancers,hepatitisC,Alzheimer’sdisease,Ebola,antibiotic-resistantsuperbugs,cardio-metabolicdiseases,andmanyothers.AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.

  In1987,MSD’sthenCEODr.P.RoyVagelosannounced,inanunprecedentedactofglobalhealthcareleadership,thatMSDwoulddonateivermectin–asmuchasneededforaslongasneeded–withthegoaltohelpeliminateriverblindness.MSDrecognizedinordertoreachthisgoal,manyorganizationswithuniqueskillswouldneedtoworktogetherasateam.Asaresult,MSDcreatedtheMectizanDonationProgram(MDP).OperatingfromtheAtlanta-basedTaskForceforGlobalHealth,theMDPcoordinatesactivitiesbetweenMSD,WHO,theWorldBankandarangeofpublicandprivatestakeholders.In1998,MSDexpandeditscommitmentfromtheMectizanDonationProgramtoincludedonatingivermectinforanotherdisease,lymphaticfilariasis(LF),alsoknownaselephantiasis,inAfricancountriesandYemenwhereitco-existswithriverblindness.ForLF,ivermectinisadministeredwithalbendazole,adrugdonatedbyGSK.AfyaSerengetiProjectFormorethan15years,haspartneredwiththe(Afyameans"health"inSwahili)intheSerengetiregionofTanzaniaineasternAfrica.Wehelpprovideaccesstopreventivecare,includingrabiesvaccinationsforlocaldogs.Todate,wehavedonatedtwomillionrabiesvaccinestosupportprogramsinIndia,Malawi,SriLanka,TanzaniaandUganda.Wealsoprovidetoolssuchasall-terrainvehiclesandtentstohelpmakesuretheprojectisabletoreachthemostremotecornersoftheregion.Rabiesinhumansanddomesticanimalshasnowbeenvirtuallyeliminatedfromthisareaandhumanhospitalizationsduetorabiddogbiteshavedecreased92percent.HbA1c,ameasureoftheaveragelevelofbloodsugaroverthepasttwotothreemonths,helpsyouandyourdoctorseehowwellyourdiabetestreatmentplanisworking.TherecommendedHbA1c,goalformanyadultswithtype2diabetesislessthan7%;however,thismayvarydependingontheindividual.Highbloodsugarlevelsovertimecanputpeoplewithdiabetesatriskofmanyserioushealthproblems,suchasheartdisease,stroke,kidneydisease,blindnessandnerveproblems.That’swhyitisimportantforpeoplelivingwithdiabetestoworkwiththeirdoctortosetindividualizedgoalsanddevelopapersonalizeddiabetesmanagementplantomanagetheABCsofdiabetes:AforHbA1c,BforbloodpressureandCforcholesterol.

  Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”TheImpactofStigmatizationThesenorms,behaviors,andbeliefssurroundinghepatitisCinfectioncanleadtoalienationfromfamilyandfriends,aswellastodiscrimination(perceivedorreal)inhealthservicesandworkplaces.Indeed,manychronichepatitisCpatientsreportfeelingsofstigmatizationandsocialisolationfromtheirfriends,family,andcoworkers.WevetalkedtoHCVinfectedgrandmotherswhoseownchildrenwon’tallowthemtoplaywiththeirgrandchildrenbecausethey’reafraidofsomesortoftransmission,reportsMichaelNinburg,executivedirectoroftheHepatitisEducationProject,aSeattle-basedgroupfoundedin1993toprovideeducation,support,andadvocacyforthoselivingwithhepatitis.ArecentlydiagnosedpatientwhoworkswithMichael’sgroupechoedthissentiment.I'msuperoutgoing.ItalkabouteveryfeelingIhavetomyfriends,justaboutanybody,andmydiagnosiswassomethingIcouldnottalkabout,hesaid.IknewthatIhadtodosomethingaboutit,butIwasashamed.Antibioticshaverevolutionizedmedicineinmanyrespects,andcountlessliveshavebeensaved;theirdiscoverywasaturningpointinhumanhistory.Foralmostacentury,bacteria-fightingdrugsknownasantibioticshavehelpedtomanagemanyoftheharmfulbacteriathatcanmakeussick.Butinrecentdecades,theyhavebecomelesseffectiveagainstsometypesofbacteria.Currently,certainbacteriaarenowunbeatablewithtoday’smedicines.Unfortunately,newdrug-resistant“superbugs”haveemerged,whicharestrainsofbacteriathatareresistanttoseveraltypesofantibiotics.Infact,theWorldHealthOrganizationhasclassifiedthisas“aseriousthreat[that]isnolongerapredictionforthefuture,itishappeningrightnowineveryregionoftheworldandhasthepotentialtoaffectanyone,ofanyage,inanycountry.”

责任编辑:www.sss403.com_老品牌信最新申博网址社友网:未经授权不得转载
关键词 >>

继续阅读

热新闻

热话题

热门推荐

关于我们 联系我们 版权声明 网站地图
百站百胜: 施密特:李可打满全场不容易大宝证明自己是好前锋 韓訪港澳引爭議盧秀燕:中央不鼓勵就明講不要扯後腿 应急部回应消防新制服“火焰蓝”色:体现职业责任 工行2018年业绩:日赚8.18亿对公理财收入同比降… 英国财政大臣:罢免首相特里莎·梅于英国无益 卡戴珊流泪痛哭怒斥TT出轨感觉TT可能还爱她 中国“智造”的抗癌药,让全球肺癌患者看到了新希望 彭剑锋:国企人才制度改革为什么要向华为海尔学习? 科通芯城3月29日回购45万股耗资129万港币 苹果自救:中国市场软硬不吃? 青岛高校新增43个本科专业人工智能等专业占一半 孙杨800米创最佳:我做到了前无古人奥运差这一金 索尼将关闭北京手机工厂迁往泰国以降低成本 股东违约海航凯撒旅游集团股份遭被动减持1885万股 2018电视剧产业调查报告发布剧集网播量首下滑 FE三亚站落幕新浪全方位助力全球顶级赛事IP 李梅丽自称是“张紫妍第二”曝大学时车里遭侵犯 脱欧大戏本周继续欧元、英镑、澳纽最新外汇分析 這些年被踢爆的「生技現形記」人人很會演 巴萨主帅:能执教梅西是种奢侈只愿他感到满意 假如遇到中兴事件怎么办?郭平:华为自有备胎计划 打回原形!普神水土不服致进攻瘫痪多1人也没优势 李光洁“偶遇”苏明成调侃郭京飞:你说得对 \"金牌月嫂\"含金量究竟几成?七天速成教学师资成谜 英议会下院将表决“脱欧”协议的法律文本 十一个关键词揭示《都挺好》幕后的爆款秘密 干细胞再生让大脑“年轻” 潘玮柏罗志祥现身西门町粉丝直呼:求偶遇! 欧盟初步通过版权法谷歌、FB商业模式将受深远影响 美國最危險的景點,每年都有人墜崖,遊人卻越來越多! 日本歌迷悼念张国荣离世16年1339只千羽鹤有寓意 “耍”了全美国和总统却没事?川普:耻辱!重审! 吃下去的益生菌,你怎么知道它不会变异? 辜寬敏:賴清德登記前致電要我別批評蔡英文 彭博:无现金零售店应被禁止是对低收入消费者的歧视 冠军赛闫子贝50蛙夺冠平纪录杨浚瑄卫冕200自 曝宝马戴姆勒联手打造电动车平台首款车型i2在2024… 《师父》为年轻人\"充电\"大张伟刘宇宁拜师\"取经… 少女时代再度合体重聚互动温馨铁粉泪崩 太惨!阿森纳要卖人省钱厄齐尔+姆希塔良全走 金融风暴眼:土耳其再度股汇债三杀对A股影响几何 张杰:要把金融权利还给乡土而非空悬在制度表层 蘋果推新聞訂閱會不會拉走媒體原始訂戶? 寒门再难出贵子在美国哈佛之路从幼儿园就决定 教育部:同济等35所高校将增设人工智能本科专业 美在建驱逐舰在船厂被撞入列时间或被推迟 名局!对轰7球!3-1变3-3不算完读秒世界波绝杀 《都挺好》大结局了这些隐藏的苏州美食你还不知道 44岁李玟自曝冻龄靠科技,网友:真是耿直girl 谢沛恩剧中女扮男装剪短发郭雪芙直呼被电到 高盛与苹果合作推出AppleCard但自家分析师并不… 桃田贤斗:大马赛渴望金牌用表现弥补偶像的缺席 17助5断+抢球迷爆米花!湖人夏天该不该留隆多 我陆军将军们时隔9个月再模拟打仗透露什么信号? 越南媒体人阮英俊:电视媒体也需要用互联网思维 物管股有追捧佳兆业物业升逾5.04%绿城服务涨约3% 王朝对决变成闷战一场!恒大三连胜却高兴不起来 佩雷拉:现在谈论争冠实力还早谈奥斯卡伤病情况 专业机构:英国“硬脱欧”或让欧洲旅游业很受伤 博鳌亚洲论坛2019年年会设五大板块议题探讨世界经济前… dailynewsus-waproll",id:"",cType:"col 野村:下调周生生目标价至14.8元维持买入评级 小米扛着一场战役:可能是雷军最好也是最后一次机会 廖晓淇:跨境电商国际争端解决机制在讨论 钻石联赛上海站首批参赛名单苏炳添领衔中国五将 ofo回应“内部反腐”行动:将继续保持高压态势 美光最新财报电话会议透露了三个重要观点 吴晓波回应全通教育收购:在做一件冒险的事内心平静 西媒感叹武磊影响力西人将加大中国球员引进力度 习近平开始对摩纳哥公国进行国事访问 米家手持无线吸尘器发布:大吸力米粉首发价1199元 任职新岗2个月卸任他曾是全国著名“反腐先锋” 0-2后无人生还!深圳青年军能否绝地求生? 拐点已至?招行等前五大私人银行AUM增速悉数放缓 阿里巴巴证实全资收购协作软件平台Teambition 花旗解读阿里投资趣头条巨头抢占新兴市场流量入口 偶像松下玲绪菜被曝光未成年饮酒暂停活动反省 福州活人墓现象:屡禁不止异化成当地炫富方式 趣头条与阿里达成贷款协议将获1.71亿美元贷款 致吉诺比利-此去经年千般念,银黑中最炫彩的帆 有马甲线的更美6组动作练出马甲线! 别被“韩流”光鲜外表迷惑外媒:阴暗面令人不堪 王简嘉禾:破亚洲纪录没想过发育期体重浮动较大 自然资源部:不动产登记办理明年底前力争再压缩 40岁大妈长腿翘臀D罩杯小鲜肉老公爱健身! 社保缴费基数要降了你能少交多少钱? 2019年独角兽的特点:估值高商业模式多样持续亏损 【乾貨】為什麼房租這麼貴呢? 韩国朝鲜跆拳道示范团下月在瑞士举行联合演出 美联储放鸽推升金价之际空头大规模出逃 卡塔尔公开赛日本队受打击马龙强势回归鼓士气 \"深度学习\"奠基人特伦斯:人工智能和大脑正走向一起 不完美的普通人面对苏大强式父母该如何尽孝? 金山软件:2018年度纯利减少88%至3.89亿元不… 台媒:欧盟通过塑料禁令将禁用一次性塑料产品 新疆足协进行换届选举孙继海当选新疆足协副主席 媒体谈武大樱花事件:自信的中国人没那么脆弱 洪涛股份分公司职业教育项目停滞能否化解困局? 意大利经济副部长:加入\"一带一路\"是补回失去的时间 李彦宏:百度下半年将落地自动驾驶出租车 男友冷暴力代表要分手?教你三招化解“危机” 一汽-大众大众品牌全系降价:最高降幅8千元 金山软件:2018年度纯利减少88%至3.89亿元不… 傅园慧:自由泳是客串抱紧我队友们的大腿! 保利置业随市飙逾10.46%绩后获瑞信升评级 何小鹏:2021年电动汽车将进入新阶段目前是成长期 小黄狗实控人自首易事特1.5亿投资和30亿承诺单悬了 全国游泳冠军赛辛鑫女子800自预赛第一(多图) 胡锡进:今日台湾就是1949年被合围的北平! FF九城签协议,贾跃亭第三次“联姻”能否解燃眉之急 波什:我认为自己是史上最杰出的球员之一 Jennie和Baby变身仙女的秘诀就是这条风琴褶裙 A股迎百亿财产分割案:徐翔老婆要离婚 趣头条获阿里投资股价先涨后跌收盘微跌0.35% 用户因Note7自燃起诉四年二审认定三星赔偿但没欺诈 美国《贸易壁垒报告》批评日本对农产品征收高关税 中国建材仍随市跌近4%去年多赚63% 亿达中国预计归属股东净利润下滑不派末期股息 西班牙人与北京足校达成青训合作下个武磊在这? 金砖国家开发银行副行长:加强新兴经济体发展需4件事 杜锋的大幸福和小烦恼王炸组合该怎么用 中国再保险:提名汪小亚为非执行董事候选人 为什么不可随便深蹲?深蹲不对造成这3个危害 北京商住房限购两年:成交量暴跌九成均价降三成 亚马逊与大众达成战略合作联手开发“工业云” 冠军赛何峻毅100自48秒10夺冠今年世界排名第二 高盛:万科企业目标价升至37.1元维持中性评级 补贴大退坡,对国产新能源车企是危机或转机? 韦世豪谈铲人:太想赢不是故意的伤病难免很正常 意移动支付势头迅猛报告:年交易额或达百亿欧元 韩国第一普拉提美女晒健身照被称为女神是有原因 马斯克暗示:特斯拉电动皮卡牵引能力将完败竞争对手 汇丰:维持海通国际买入评级目标价降至3.7港元 汇丰:维持海通国际买入评级目标价降至3.7港元 经济增长放缓通胀压力消退新兴国家或掀降息潮 郭鹤立任甘肃临夏州委书记杨元忠另有任用 开盘:关注贸易谈判进展美股高开道指涨140点 马刺雷霆一战锁定季后赛!西部前八名全部确定 “好胆固醇”越多越好?观念要变了! 葡联赛-凯维赛尔失单刀鲁茸锴翥首发提前4轮保级 内陆省市外贸异军突起背后是贸易结构升级 破次元壁?歌迷向A妹安利BLACKPINK获本尊回复 兰姆神奇三分压哨绝杀!卡哇伊28分猛龙负黄蜂 2018年城市抢人大战结果揭晓:深圳广州西安排前三 三个月过去你的ofo退押金排号前进了多少位? 如何投资5G:买入这2只基金10只股票就够了 最大泡沫之一比特币被刺破三大矿机巨头IPO遭遇团灭 华为P30背后的较量:OPPOvivo诺基亚等厂商拼拍… 薛佳凝与神秘男牵手回家疑恋情曝光经纪人表示不知情 临近周期结束全球债券市场狂欢者保持清醒头脑 弗洛雷斯:间歇期调整出色以最佳状态迎战建业 中国体操的使命是什么?杨威一堂课唤醒全队血性 财政部等解读:为何降低新能源汽车补贴标准 青岛高校新增43个本科专业人工智能等专业占一半 \"金牌月嫂\"含金量究竟几成?七天速成教学师资成谜 台大個人申請一階篩選102人通過五系篩選 美联储副主席Clarida表示必须密切关注全球风险 老卡特成NBA历史第5!再打一年吧!稳超斯托克顿 俄出兵委内瑞拉后设立直升机训练中心协助部署S300 中国台北奥运冠军涉药禁赛撞脸陈奕迅之人也中招 她长相很一般健身前后却判若两人! 日本世游赛选拔明日打响濑户大也:要充满干劲 美国将全面改革航空安全监管规则 响水一化工厂19吨液氯储罐阀体泄漏消防完成排险 57+61!疯狂两战让主帅拜服就因这不轮休哈登 新款MINICLUBMAN实车曝光换装全新样式灯组 余文乐儿子傻看爸妈玩亲亲露白嫩婴儿肥呆萌可爱 女性独立买房激增正带来“独立”婚姻观 德国瓦克化学董事Hartel:需要创新技术提高整个行业 连个颁奖仪式都没有?亚当斯体验后补外援待遇 男子每天跑步5-10公里30天后腹肌清晰可见 让梅西累死?巴萨主帅:梅西没有理想轮休时间 中介机构被调查影响博纳上市?已恢复审核拿到牌照 马龙:比赛重新找回感觉拿多哈冠军比其他都开心 弗格森知恩图报!捐款40万镑谢脑溢血后救命之恩 网票网让猫眼亏至少1个亿1.3亿\"接盘\"2200… 现代牙科3月29日回购10万股耗资13万港币 三大航去年净赚130亿扣非净利润却都在下降 杠铃划船的四大训练优势 中国(国际)体育场地检测认证?上海高峰论坛落幕 松重丰出道34年首次主演电影应对日本少子化现象 野村:东风集团目标价降至9元维持中性评级 2018年四大行开发贷余额突破3万亿同比增长12.7… “17”有特别意义?向佐评论郭碧婷17颗心引猜测 今晚美国GDP等重磅数据来袭金银巨震在即 曝锦户亮与船越英一郎聚会疑商谈退团后发展 李若彤自曝爱独自健身轻松举哑铃手臂线条紧实 投资者蜂拥出逃股票基金为何美股一季度历史性大涨 三厢性能“暴徒”曝全新AMGA35官图 韦世豪专程去医院看望被铲伤球员当面表达歉意 女强男弱贾乃亮王鸥《推手》成反向“青蛙王子” 布鲁克斯:如果热火允许韦德退役,他们该被罚款 联讯策略:下跌抵抗如期出现如何应对结构性行情 周黑鸭被做空后上市鸭脖“三剑客”将何去何从? 燕潮大桥正式通车北京六环到燕郊仅需15分钟 第九城市盘前涨超20%上演过山车行情 李克强会见萧万长一行